drugset / Trial / NCT06316362

Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine

NCT06316362 ↗

Phase 2 Completed 40 enrolled Alexandria University
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of the current study was to evaluate whether SMOF lipid administration could be used as an adjuvant therapy to treat acute, moderate-to-severe carbamazepine poisoning.

Timeline

Start
2022-01-01
Primary completion
2023-02-01
Completion
2023-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator SMOF Other / unclassified 6 unknown Intravenous

Indications